From €127EUR$129USD£106GBP
- Book
- April 2018
- 486 Pages
- Book
- January 2012
- 123 Pages
- Training
- 2 Hours
Global
- Webinar
- 60 Minutes
Global
From €148EUR$150USD£123GBP
- Report
- July 2024
- 280 Pages
Global
From €2622EUR$2,655USD£2,186GBP
- Report
- July 2024
- 233 Pages
Global
From €2622EUR$2,655USD£2,186GBP
- Report
- July 2024
- 280 Pages
Global
From €2622EUR$2,655USD£2,186GBP
- Report
- April 2024
- 350 Pages
Global
From €3793EUR$3,840USD£3,161GBP
- Report
- December 2023
- 302 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- November 2023
- 451 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- August 2023
- 293 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- June 2023
- 243 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- April 2023
- 252 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- March 2023
- 262 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- February 2023
- 300 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- December 2022
- 235 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- December 2022
- 229 Pages
Global
From €3526EUR$3,570USD£2,939GBP
- Report
- November 2022
- 310 Pages
Global
From €3793EUR$3,840USD£3,161GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more